CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001
Go back to CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001| (NASDAQ: CRSP) | Delayed: 54.78 -1.01 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.79 | 52 Week High | $18.88 | |||
| Open | $54.45 | 52 Week Low | $13.75 | |||
| Day High | $55.10 | P/E | N/A | |||
| Day Low | $52.78 | EPS | $0.00 | |||
| Volume | 1,384,588 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 528.90 -17.22 (3.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $546.12 | 52 Week High | $134.71 | |||
| Open | $529.64 | 52 Week Low | $73.31 | |||
| Day High | $535.00 | P/E | N/A | |||
| Day Low | $520.20 | EPS | $-1.98 | |||
| Volume | 1,090,972 | |||||
